Clinical Trial Design and Success Prediction Report

Utilising TrialGen, TrialKey’s AI-driven clinical trial design simulation tool, our custom clinical trial reports provide comprehensive, actionable insights to enhance trial success rates, optimise resource allocation, and accelerate market entry.

What is Included?

Trial Overview and Success Rate

  • Study Design

    Detailed description of the trial phase, type, and methodology.

  • Phase Completion Prediction:

    Utilises our advanced AI model to forecast trial phase completion with over 92% accuracy.

Study Design Optimisation

  • Endpoints

    Recommends the most relevant and impactful primary and secondary endpoints tailored to the specific goals of the trial. TrialGen's AI analysis identifies endpoints that align with regulatory requirements and improve trial outcomes.

  • Inclusion/Exclusion Criteria

    Delivers detailed patient selection criteria to optimise recruitment and minimise dropout rates. Incorporates data-driven insights to rank criteria based on their impact on trial success, ensuring the right patient population.

  • Study Arms

    Provides recommendations on the optimal number and structure of study arms, including control groups and crossover designs, to ensure robust and meaningful comparisons. This helps in refining study methodologies and enhancing statistical power.

  • Duration

    Analyses trial duration to identify the optimal timeframe for success. Factors such as therapeutic area, historical data, and study objectives are considered, ensuring trials are neither too short to yield meaningful results nor too long, thereby conserving resources.

Study Impacts

  • Positive and Negative Factors

    Comprehensive analysis of factors influencing trial outcomes. This includes:

  • Patient Enrolment

    Optimal number of patients to ensure statistical power and meaningful results without unnecessary costs.

  • Geographic Distribution

    Ideal number and location of study sites to maximise recruitment and retention. Analysis of country-specific impacts on success rates.

  • Patient Touchpoints

    Recommendations on the frequency and nature of patient interactions to maintain engagement and compliance without overwhelming participants.

  • Sponsor Track Record

    Historical success rates of the sponsor and their impact on the current trial's probability of success.

  • Technology Related

    Evaluates technologies employed in the trial, such as drug mechanisms, administration methods, and virtual patient monitoring, to understand their influence on outcomes.

  • Adverse Event Prediction

    Predicts potential serious adverse events, providing risk mitigation strategies to ensure patient safety and trial success.

  • Feature Contribution Analysis

    Breaks down how specific trial features contribute to overall trial success, helping researchers focus on the most critical elements for design optimisation.

Competitor and Market Analysis

  • Successes and Failures

    Provides historical data on similar trials, highlighting successful strategies and common pitfalls to guide trial design and execution.

  • Competitor Benchmarks

    Delivers detailed comparisons with competitor trials, including success probability scores, visual benchmarking graphs, and key findings to understand relative strengths and weaknesses.

  • Market Trends

    Analyses current trends in the clinical trial landscape, identifying emerging opportunities and potential threats. Offers an overview of the competitive landscape for strategic market positioning.

Visualisation and Reporting

  • Probability Density Graphs:

    Displaying the distribution of success probabilities from multiple trial simulations, highlighting confidence intervals and expected success rates.

  • Feature Impact Charts:

    Visual breakdown of how different trial features affect the likelihood of success, helping to identify the most critical variables to focus on.

  • Competitor Comparison Tables:

    Side-by-side comparisons of your trial’s success probabilities with those of close competitors, highlighting areas of strength and potential improvement.

  • Executive Summary:

    Concise summary of key findings and actionable recommendations tailored to the specific needs of the trial. This includes clear, high-level insights for decision-makers

Request a free Preliminary Report

Current Prediction vs TrialKey's Optimised Design

  • TrialKey predicts clinical trial outcomes using AI-powered simulations, comparing the current study design against an optimized version. Our model evaluates study parameters, benchmarks against historical trials, and recommends data-driven improvements to increase the likelihood of success. Current Study Design Projected trial performance based on the existing protocol. Optimized Study Design Improved study design incorporating TrialKey’s AI-driven recommendations, refining inclusion criteria, endpoints, and sample size for a higher probability of success. TrialKey helps you see the difference before the trial even begins.

Why Choose TrialKey?

Improved Clinical Trial Design

With only 10% of pivotal trials succeeding, poor design is a key barrier. TrialKey uses advanced AI-driven biostatistical validation, analysing a real-world dataset of over 468,429 trials trials to simulate and optimise study designs. 

Cost Efficiency

Amendments to trial protocols are costly, resulting in delays and increased expenses. TrialKey’s AI-powered platform predicts patient dropout rates, forecasts trial duration, and identifies potential adverse events, reducing the need for costly amendments and keeping trials on track.

High Accuracy

TrialKey provides data-backed insights with over 92% accuracy in predicting trial phase completion, making it a market leader in clinical trial optimisation. Our explainable AI framework ensures transparency in recommendations, validated by subject matter experts.

Comprehensive Analysis

Access a vast spectrum of clinical trials, including medical devices, alternative therapies, rare conditions, and novel treatments. Our platform goes beyond traditional analysis, employing Natural Language Processing (NLP) to extract critical insights from free-text trial entries, journal articles, and other sources.

Actionable Insights

TrialKey’s advanced simulator runs up to 100,000 trial scenarios, offering a near-realistic preview of trial performance based on its design. Gain data-driven protocol recommendations, competitor benchmarking, and insights into optimal study arms, patient interactions, and site selection.

Resource Optimisation

Our AI-driven approach ensures efficient resource allocation by identifying trials with the highest potential for success. This includes precise patient enrolment strategies, geographic distribution analysis, and country-specific recommendations, ultimately benefiting patients and healthcare systems worldwide.

Optimised Trials: AI-powered graphics by TrialKey enhancing clinical trial design for biotech and pharmaceutical industries